Ketoconazole
Top View
- Hovey Et Al. (45) Date of Patent: *May 26, 2015
- Clinical Trials, Progression-Speed Differentiating Features, and Swiftness Rule of the Innovative Targets of First-In-Class Drugs
- Pharmacokinetics, Metabolism and Excretion
- MIFEPREX (Mifepristone) Tablets, for Oral Use Initial U.S
- Interactions Drug
- Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation
- SPG Therapeutics, Inc
- Appendix B - Product Name Sorted by Applicant
- NIH Public Access Author Manuscript Eur J Pharm Sci
- Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide
- PRISTIQS; INN: Desvenlafaxine
- Ketoconazole Tablets Rationale for Inclusion In
- Predicting Drug Responses by Propagating Interactions Through Text-Enhanced Drug-Gene Networks
- 1 Aldosterone Inhibitors in Infants and Children
- A Phase II Study of Increased-Dose Abiraterone Acetate in Patients with Castration Resistant Prostate Cancer (CRPC)
- Draft Guidance on Ketoconazole
- Treatment of Mucormycosis
- State Biorelevant Media (Fassif and Fassif-V2)